The email sent will contain a link to this article, the article title, and an article excerpt (if available). For security reasons, your IP address will also be included in the sent email.
Nina Totenberg
March 22, 2011
http://www.npr.org/2011/03/22/134771092/Supreme-Court-Rules-Against-Drug-Company
In a unanimous ruling with particular significance for the pharmaceutical industry, the U.S. Supreme Court has allowed investors to sue the maker of Zicam cold remedies.
The decision firmly rebuffs an effort by corporations seeking to make it more difficult to bring investor lawsuits.
Usually, lawsuits against a drug manufacturer are brought by consumers who allege they were harmed by the product. But Tuesday's case involved a class action brought by investors against Matrixx Initiatives Inc., the maker of Zicam products.